Literature DB >> 31509010

Regulation of mitochondria function by natriuretic peptides.

Mark Domondon1, Anna B Nikiforova1,2, Kristine Y DeLeon-Pennell3,4, Daria V Ilatovskaya1,5.   

Abstract

Natriuretic peptides (NPs) are well known to promote renal Na+ excretion, counteracting the effects of the renin-angiotensin-aldosterone system. Thus, NPs serve as a key component in the maintenance of blood pressure, influencing fluid retention capabilities via osmoregulation. Recently, NPs have been shown to affect lipolysis and enhance lipid oxidation and mitochondrial respiration. Here, we provide an overview of current knowledge about the relationship between NPs and mitochondria-mediated processes such as reactive oxygen species production, Ca2+ signaling, and apoptosis. Establishing a clear physiological and mechanistic connection between NPs and mitochondria in the cardiovascular system will open new avenues of research aimed at understanding and potentially using it as a therapeutic target from a completely new angle.

Entities:  

Keywords:  atrial natriuretic peptide; cGMP; guanylate cyclase; mitochondria; natriuretic peptides

Mesh:

Substances:

Year:  2019        PMID: 31509010      PMCID: PMC6879937          DOI: 10.1152/ajprenal.00384.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  53 in total

1.  Physiological role of silent receptors of atrial natriuretic factor.

Authors:  T Maack; M Suzuki; F A Almeida; D Nussenzveig; R M Scarborough; G A McEnroe; J A Lewicki
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

2.  8-pCPT-cGMP prevents mitochondrial depolarization and improves the outcome of steatotic partial liver transplantation.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

3.  B-type natriuretic peptide protects cardiomyocytes at reperfusion via mitochondrial calcium uniporter.

Authors:  Yiguo Sun; Tongle Deng; Na Lu; Ming Yan; Xiaoxiang Zheng
Journal:  Biomed Pharmacother       Date:  2010-01-09       Impact factor: 6.529

4.  Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore.

Authors:  K Takuma; P Phuagphong; E Lee; K Mori; A Baba; T Matsuda
Journal:  J Biol Chem       Date:  2001-10-24       Impact factor: 5.157

5.  A mitochondrial protein compendium elucidates complex I disease biology.

Authors:  David J Pagliarini; Sarah E Calvo; Betty Chang; Sunil A Sheth; Scott B Vafai; Shao-En Ong; Geoffrey A Walford; Canny Sugiana; Avihu Boneh; William K Chen; David E Hill; Marc Vidal; James G Evans; David R Thorburn; Steven A Carr; Vamsi K Mootha
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

6.  The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells.

Authors:  Mariela Susana Borán; María Antonia Baltrons; Agustina García
Journal:  Glia       Date:  2008-03       Impact factor: 7.452

7.  Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury.

Authors:  Hazel H Szeto; Shaoyi Liu; Yi Soong; Nazia Alam; Glen T Prusky; Surya V Seshan
Journal:  Kidney Int       Date:  2016-08-09       Impact factor: 10.612

8.  Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney.

Authors:  M Marin-Grez; J T Fleming; M Steinhausen
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

9.  Recombinant Atrial Natriuretic Peptide Prevents Aberrant Ca2+ Leakage through the Ryanodine Receptor by Suppressing Mitochondrial Reactive Oxygen Species Production Induced by Isoproterenol in Failing Cardiomyocytes.

Authors:  Wakako Murakami; Shigeki Kobayashi; Takehisa Susa; Takuma Nanno; Hironori Ishiguchi; Takeki Myoren; Shigehiko Nishimura; Takayoshi Kato; Akihiro Hino; Tetsuro Oda; Shinichi Okuda; Takeshi Yamamoto; Masafumi Yano
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

Review 10.  The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective.

Authors:  Shalini M Krishnan; Jan R Kraehling; Frank Eitner; Agnès Bénardeau; Peter Sandner
Journal:  Int J Mol Sci       Date:  2018-06-09       Impact factor: 5.923

View more
  5 in total

Review 1.  Hormonal Regulation of Renal Fibrosis.

Authors:  Polina A Abramicheva; Egor Y Plotnikov
Journal:  Life (Basel)       Date:  2022-05-16

2.  Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in db/db mice and KKAy mice compared with valsartan treatment.

Authors:  Komuraiah Myakala; Bryce A Jones; Xiaoxin X Wang; Moshe Levi
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-19

3.  Effects of elevation of ANP and its deficiency on cardiorenal function.

Authors:  Daria V Ilatovskaya; Vladislav Levchenko; Kristen Winsor; Gregory R Blass; Denisha R Spires; Elizaveta Sarsenova; Iuliia Polina; Adrian Zietara; Mark Paterson; Alison J Kriegel; Alexander Staruschenko
Journal:  JCI Insight       Date:  2022-05-09

Review 4.  Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease.

Authors:  Alexandra Ioana Moatar; Aimee Rodica Chis; Catalin Marian; Ioan-Ovidiu Sirbu
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

5.  Mitochondria, a Missing Link in COVID-19 Heart Failure and Arrest?

Authors:  Ralph Ryback; Alfonso Eirin
Journal:  Front Cardiovasc Med       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.